Fed. Circ. Affirms Partial Ax Of Guardant Genetic Test Patent
The Federal Circuit has backed a Patent Trial and Appeal Board panel's decision to invalidate some claims in a genetic testing patent held by health care technology company Guardant Health, agreeing...To view the full article, register now.
Already a subscriber? Click here to view full article